When he walks into Dana-Farber Cancer Institute every day, medical oncologist Brian Wolpin, MD, MPH, isn’t just prepared to treat the patients who await him inside. As director of Dana-Farber’s Gastrointestinal Cancer Center and Hale Center for Pancreatic Cancer Research, he’s also constantly thinking about how new research could improve outcomes for patients with gastrointestinal cancer in the future.
“We are continually doing more science and more work so that we can improve the care for our patients,” he says. “That is why I show up every day. I want our group to treat patients today with the upmost compassion and informed by the latest science. At the same time, we want to ensure that the treatments we have to help patients tomorrow are even better than what we have available today.” Read the story.